Search Results 591-600 of 14849 for smoothie formulas

1. Medical Research & Education - Mayo Clinic News Network

   If you're at risk of heart disease, your healthcare team might use the pooled cohort equation (PCE) tool to determine your long-term risk and whether taking ...

2. Associated Anomalies with Right and Left Cusp Fusion Versus Right and Non-Coronary Cusp Fusion - Mayo Clinic

   About this study. The goal of this study is to determine whether significant differences exist in the prevalence of associated cardiac anomalies between ...

3. First In Human Study Of KO-539 To Treat Relapsed Or Refractory Acute Myeloid Leukemia - Mayo Clinic

   creatinine clearance (CLcr) ≥ 60 mL/min using the Cockcroft-Gault equation. Hydroxyurea will be allowed prior to enrollment and after the start of KO-539 ...

4. A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease - Mayo Clinic

   eGFR ≥25 and ≤75 mL/min/1.73m2 (CKD-EPI Formula) at visit 1; Evidence of increased albuminuria 3 months or more before visit 1 and UACR ≥200 and ≤5000 mg ...

5. CT Angiography of the Aorta following Fenestrated Branched Endovascular Aneurysm Repair (F-BEVAR) using Tube Potential Selection and Weight-based Method: Effects on Image Quality and Radiation Dose - Mayo Clinic

   CT Angiography of the Aorta following Fenestrated Branched Endovascular Aneurysm Repair (F-BEVAR) using Tube Potential Selection and Weight-based Method: ...

6. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

   calculated creatinine clearance, estimated glomerular filtration rate 9eGFR ≥ 60 mL/min (MDRD formula). normal bood urea nitrogen (BUN) unless considered ...

7. Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA) - Mayo Clinic

   Inclusion Criteria. Patient must be ≥ 18 years of age. Patient must have been seen by a rheumatology health care provider at least two times within the ...

8. A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis - Mayo Clinic

   About this study. The purpose of this study is to assess whether our not the percentage of pulmonary related vascular structures (PRVS) determined by the ...

9. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Dasatinib, imatinib mesylate, and nilotinib may ...

10. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting - Mayo Clinic

    Creatinine clearance < 30 mL/min at screening or within 90 days of screening using the Cockcroft-Gault formula in participants ≥ 18 years of age or ...